Infiltration of immune cells to the brain and its relation to the pathogenesis of Alzheimer's and Parkinson's diseases

被引:4
|
作者
Netzahualcoyotzi, Citlalli [1 ,2 ,5 ]
Santillan-Cigales, Juan Jair [1 ]
Adalid-Peralta, Laura Virginia [2 ]
Velasco, Ivan [1 ,2 ,3 ,4 ]
机构
[1] Univ Nacl Autonoma Mexico, Inst Fisiol Celular Neurociencias, Mexico City, Mexico
[2] Inst Nacl Neurol & Neurocirugia Manuel Velasco Sua, Lab Reprogramac Celular, Mexico City, Mexico
[3] Univ Nacl Autonoma Mexico, Inst Fisiol Celular Neurociencias, Mexico City 04510, Mexico
[4] Inst Nacl Neurol & Neurocirugia Manuel Velasco Sua, Lab Reprogramac Celular, Mexico City 14269, Mexico
[5] Ctr Invest & Estudios Avanzados CINVESTAV, Dept Farmacol, Mexico City, Mexico
关键词
Alzheimer's disease; blood-brain barrier; leukocytes; neuroimmunology; neurovascular unit; Parkinson's disease; CENTRAL-NERVOUS-SYSTEM; AMYLOID-BETA-PROTEIN; CD8; T-CELLS; ALZHEIMERS-DISEASE; MAST-CELLS; MOUSE MODEL; IFN-GAMMA; BARRIER PERMEABILITY; NEUROVASCULAR UNIT; MICROGLIAL ACTIVATION;
D O I
10.1111/jnc.16106
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The neurovascular unit, composed of vascular endothelium, vascular smooth muscle, extracellular matrix components, pericytes, astrocytes, microglia, and neurons, allows the highly regulated exchange of molecules and the limited trafficking of cells to the brain through coordinated signaling activity. The passage of peripheral immune cells to the brain parenchyma is observed when there is clear damage to the barriers of this neurovascular unit, as occurs in traumatic brain injury. The possibility of leukocyte infiltration to the brain in neurodegenerative conditions has been proposed. In this review, we focus on describing the evidence for peripheral immune cell infiltration to the brain in the two most frequent neurodegenerative diseases: Alzheimer's and Parkinson's diseases. In particular, we address the mechanisms that promote the passage of these cells into the brain under such pathological conditions. We also discuss the relevance of the resulting cellular interactions, which provide evidence that the presence of peripheral immune cells in the brain is a key point in these neurodegenerative diseases. The disruption of the neurovascular unit and the infiltration of the peripheral immune cells into the central nervous system are hallmarks of neurodegenerative diseases. However, so far, the participation of infiltrating cells in the progression of these diseases has not been completely defined. In this work, we gather the evidence that exists until now which proposes the key events involved in the pathogenesis of the two main neurodegenerative diseases: Alzheimer's and Parkinson's diseases. We detail the alterations in the components that typically keep the neurovascular unit semi-permeable to the cellular interactions that promote a self-perpetuating cycle of inflammation.image
引用
收藏
页码:2316 / 2334
页数:19
相关论文
共 50 条
  • [41] In silico and pharmacokinetic studies of glucomoringin from Moringa oleifera root for Alzheimer's disease like pathology
    Manogna, Chintalapati
    Margesan, Thirumal
    FUTURE SCIENCE OA, 2024, 10 (01):
  • [42] Preliminary translation of 'Reducing Disability in Alzheimer's Disease' among individuals with intellectual disabilities and caregiver dyads
    Ptomey, Lauren T.
    Barton, Kelli
    Swinford, Emma
    Bodde, Amy
    George, Amanda
    Gorczyca, Anna M.
    Niedens, C. Michelle
    Sprague, Susan C.
    Yeager, Amy
    Helsel, Brian
    Teri, Linda
    Vidoni, Eric D.
    Perales-Puchalt, Jaime
    JOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES, 2024, 37 (03)
  • [43] Label-free detection of Aβ-42: a liquid crystal droplet approach for Alzheimer's disease diagnosis
    Pradhan, Saumya Ranjan
    Pathinti, Ramadevi Suguru
    Kandimalla, Ramesh
    Chithari, Krishnakanth
    Veeramalla, N. Madhava Rao
    Vallamkondu, Jayalakshmi
    RSC ADVANCES, 2024, 14 (17) : 12107 - 12118
  • [44] A multi-omics study to monitor senescence-associated secretory phenotypes of Alzheimer's disease
    Yang, Jingzhi
    Zhou, Yinge
    Wang, Tianjiao
    Li, Na
    Chao, Yufan
    Gao, Songyan
    Zhang, Qun
    Wu, Shuo
    Zhao, Liang
    Dong, Xin
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (05): : 1310 - 1324
  • [45] The Innate and Adaptive Immune Cells in Alzheimer's and Parkinson's Diseases
    Huang, Boyuan
    Zhenxin, Yan
    Chen, Sisi
    Tan, Zhenhua
    Zong, Zhitao
    Zhang, Hongbo
    Xiong, Xiaoxing
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
  • [46] Repurposing non-pharmacological interventions for Alzheimer's disease through link prediction on biomedical literature
    Xiao, Yongkang
    Hou, Yu
    Zhou, Huixue
    Diallo, Gayo
    Fiszman, Marcelo
    Wolfson, Julian
    Zhou, Li
    Kilicoglu, Halil
    Chen, You
    Su, Chang
    Xu, Hua
    Mantyh, William G.
    Zhang, Rui
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [47] A decision support system based on recurrent neural networks to predict medication dosage for patients with Parkinson's disease
    Riasi, Atiye
    Delrobaei, Mehdi
    Salari, Mehri
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [48] 'Draw your pelvis' test for assessing pelvic schema in people with Parkinson's disease: a validity and reliability study
    Abraham, Amit
    Wright, Gene N.
    Morrison, Margaret W.
    Hart, Ariel
    Dickstein, Ruth
    Hackney, Madeleine E.
    SOMATOSENSORY AND MOTOR RESEARCH, 2019, 36 (02): : 156 - 161
  • [49] Oligomeropathies and Pathogenesis of Alzheimer and Parkinson's Diseases
    Forloni, Gianluigi
    Artuso, Vladimiro
    La Vitola, Pietro
    Balducci, Claudia
    MOVEMENT DISORDERS, 2016, 31 (06) : 771 - 781
  • [50] Novel multifunctional tacrine-donepezil hybrids against Alzheimer's disease: Design synthesis and bioactivity studies
    Bayraktar, Guelsah
    Bartolini, Manuela
    Bolognesi, Maria Laura
    Erdogan, Mumin Alper
    Armagan, Guliz
    Bayir, Ece
    Sendemir, Aylin
    Bagetta, Donatella
    Alcaro, Stefano
    Alptuezuen, Vildan
    ARCHIV DER PHARMAZIE, 2024, 357 (07)